Correlation Between Symtek Automation and Tanvex BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Symtek Automation and Tanvex BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Symtek Automation and Tanvex BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Symtek Automation Asia and Tanvex BioPharma, you can compare the effects of market volatilities on Symtek Automation and Tanvex BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Symtek Automation with a short position of Tanvex BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Symtek Automation and Tanvex BioPharma.

Diversification Opportunities for Symtek Automation and Tanvex BioPharma

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Symtek and Tanvex is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Symtek Automation Asia and Tanvex BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tanvex BioPharma and Symtek Automation is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Symtek Automation Asia are associated (or correlated) with Tanvex BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tanvex BioPharma has no effect on the direction of Symtek Automation i.e., Symtek Automation and Tanvex BioPharma go up and down completely randomly.

Pair Corralation between Symtek Automation and Tanvex BioPharma

Assuming the 90 days trading horizon Symtek Automation Asia is expected to generate 0.84 times more return on investment than Tanvex BioPharma. However, Symtek Automation Asia is 1.19 times less risky than Tanvex BioPharma. It trades about 0.1 of its potential returns per unit of risk. Tanvex BioPharma is currently generating about 0.02 per unit of risk. If you would invest  9,348  in Symtek Automation Asia on September 12, 2024 and sell it today you would earn a total of  9,852  from holding Symtek Automation Asia or generate 105.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Symtek Automation Asia  vs.  Tanvex BioPharma

 Performance 
       Timeline  
Symtek Automation Asia 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Symtek Automation Asia are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Symtek Automation showed solid returns over the last few months and may actually be approaching a breakup point.
Tanvex BioPharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tanvex BioPharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Tanvex BioPharma is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Symtek Automation and Tanvex BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Symtek Automation and Tanvex BioPharma

The main advantage of trading using opposite Symtek Automation and Tanvex BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Symtek Automation position performs unexpectedly, Tanvex BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tanvex BioPharma will offset losses from the drop in Tanvex BioPharma's long position.
The idea behind Symtek Automation Asia and Tanvex BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Valuation
Check real value of public entities based on technical and fundamental data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets